about
Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.Increasing the minicircle DNA purity using an enhanced triplex DNA technology to eliminate DNA contaminants.Complete sequence and organization of the Sphingobium chungbukense DJ77 pSY2 plasmid.Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms.Pristine DNA Hydrogels from Biotechnologically Derived Plasmid DNA.
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Production of plasmid DNA for pharmaceutical use.
@en
type
label
Production of plasmid DNA for pharmaceutical use.
@en
prefLabel
Production of plasmid DNA for pharmaceutical use.
@en
P1476
Production of plasmid DNA for pharmaceutical use.
@en
P2093
Carsten Voss
P304
P356
10.1016/S1387-2656(07)13008-8
P577
2007-01-01T00:00:00Z